Drug resistance in anti-TNF therapy of psoriatic arthritis

Drug resistance in anti-TNF therapy of psoriatic arthritis

Bibliographic Details
Main Authors:	Dominika Ligia Wcisło-Dziadecka, Beniamin Grabarek, Ligia Brzezińska-Wcisło, Urszula Mazurek
Format:	Article
Language:	English
Published:	Termedia Publishing House 2018-11-01
Series:	Przegląd Dermatologiczny
Subjects:	anti-TNF therapy psoriasis resistance in therapy molecular marker
Online Access:	https://www.termedia.pl/Drug-resistance-in-anti-TNF-therapy-of-psoriatic-arthritis,56,34025,1,1.html

Similar Items

Signaling pathways associated with interleukins 12 and 23 and epigenetic mechanism of sequential-specific regulation of expression of related genes by miRNAs as molecular markers for assessing the potential of anti-cytokine therapies
by: Beniamin O. Grabarek, et al.
Published: (2019-03-01)

An analysis of selected factors influencing the efficacy of psoriasis therapy
by: Beniamin O. Grabarek, et al.
Published: (2020-02-01)

Nailfold Videocapillaroscopy in Patients with Rheumatoid Arthritis and Psoriatic Arthropathy on ANTI-TNF-ALPHA Therapy
by: Daniela Anghel, et al.
Published: (2023-06-01)

New-Onset Psoriatic Arthritis under Biologics in Psoriasis Patients: An Increasing Challenge?
by: Matteo Megna, et al.
Published: (2021-10-01)

Recurrent erythema nodosum and pulmonary lymph node tuberculosis in a patient treated for psoriatic arthritis and psoriasis with TNF inhibitors
by: Piotr Parcheta, et al.
Published: (2014-10-01)

Severe glandular tularemia in a patient treated with anti-tumour necrosis factor for psoriatic arthritis
by: Ruxandra Calin, et al.
Published: (2017-07-01)

The Effect of TNF-α Inhibitors on Nail Psoriasis and Psoriatic Arthritis—Real-World Data from Dermatology Practice
by: Georgios Kokolakis, et al.
Published: (2021-10-01)

Scedosporium infection in a patient with anti-tnfα therapy
by: Caroline T Nguyen, et al.
Published: (2011-01-01)

Anti-TNF Therapy in Spondyloarthritis and Related Diseases, Impact on the Immune System and Prediction of Treatment Responses
by: Silvia Menegatti, et al.
Published: (2019-03-01)

Bio‐experienced psoriasis patients treated with anti‐interleukin monoclonal antibodies are less likely to achieve PASI 90, PASI 100, PASI ≤ 1 and ≤3: Results from a cohort of 305 patients
by: Flavia Manzo Margiotta, et al.
Published: (2024-03-01)

Anti-TNF Exposure during Pregnancy in Crohn’s Disease Patients
by: Elen Farinelli de Campos Silva, et al.
Published: (2018-10-01)

Hepatorenal pathologies in TNF-transgenic mouse model of rheumatoid arthritis are alleviated by anti-TNF treatment
by: Xuefei Li, et al.
Published: (2023-10-01)

Pharmacogenetic Analysis of the <i>MIR146A</i> rs2910164 and <i>MIR155</i> rs767649 Polymorphisms and Response to Anti-TNF Treatment in Patients with Crohn’s Disease and Psoriasis
by: Paraskevi Nani, et al.
Published: (2023-02-01)

<I>TNF-α</I> gene expression in immune cells of patients with psoriasis and psoriatic arthritis
by: V. V. Sobolev, et al.
Published: (2022-08-01)

Novel Bispecific Antibody for Synovial-Specific Target Delivery of Anti-TNF Therapy in Rheumatoid Arthritis
by: Mathieu Ferrari, et al.
Published: (2021-02-01)

Psoriasis Treatment Changes the Expression Profile of Selected Caspases and their Regulatory MicroRNAs
by: Dominika Wcisło-Dziadecka, et al.
Published: (2018-10-01)

Cell proliferation and cytokine induction by TNF-α of psoriatic keratinocytes are not different from normal keratinocytes <i> in vitro</i>
by: Takahashi Hidetoshi, et al.
Published: (2009-01-01)

Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice
by: Maria Esposito, et al.
Published: (2019-07-01)

The Potential Benefits of Certolizumab Pegol in Patients with Concurrent Psoriatic Arthritis and Chronic Plaque Psoriasis: A Case Series and Review of the Literature
by: David Rutkowski, et al.
Published: (2019-03-01)

Psoriatic arthritis: treatment strategies using biologic agents
by: C. Palazzi, et al.
Published: (2012-06-01)

IgA deficiency evidence after anti-TNF-α treatment in a psoriatic arthritis patient: case report
by: R. Scarpa, et al.
Published: (2012-03-01)

IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients
by: Milena Iwaszko, et al.
Published: (2021-06-01)

Disseminated granuloma annulare: A cutaneous adverse effect of anti-TNF agents
by: Mondhipa Ratnarathorn, et al.
Published: (2011-01-01)

Editorial: Therapeutic Advancements in Psoriasis and Psoriatic Arthritis
by: Saumya Panda
Published: (2022-03-01)

Progressive rash as the first sign of Listeria meningitis and bacteremia
by: Alli J. Blumstein, BS, et al.
Published: (2022-10-01)

Immunogenicity to biological drugs in psoriasis and psoriatic arthritis
by: Fernando Valenzuela, et al.
Published: (2021-10-01)

Analysis of factors predisposing to the occurrence of psoriasis among patients qualified for cyclosporine A therapy – a pilot study
by: Beniamin O. Grabarek, et al.
Published: (2019-06-01)

Properties of Fluorescent Far-Red Anti-TNF Nanobodies
by: Ekaterina N. Gorshkova, et al.
Published: (2018-12-01)

Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet’s disease in Taiwan
by: Ya-Chiao Hu, et al.
Published: (2019-07-01)

Targeting AQP9 enhanced the anti-TNF therapy response in Crohn's disease by inhibiting LPA-hippo pathway
by: Minhao Yu, et al.
Published: (2024-05-01)

Delayed anti-TNF therapy increases the risk of total knee replacement in patients with severe rheumatoid arthritis
by: Ying-Chou Chen, et al.
Published: (2017-08-01)

The Role of IL-18, TNF-α and hs-CRP among Iraqi psoriatic Patients and their Correlation with Disease Severity
by: Suzan Yousif Jasim
Published: (2018-03-01)

Long-term safety and efficacy of anti-tumor necrosis factor-alpha biosimilar agents in the treatment of psoriasis: a single center study
by: Federica Ricceri, et al.
Published: (2022-05-01)

Monitoring of patients with rheumatoid arthritis by indocyanine green (ICG)-enhanced fluorescence optical imaging treated with anti-TNFα therapy
by: S. Hertrampf, et al.
Published: (2022-05-01)

The use of ustekinumab in patients with psoriasis and coexisting renal or hepatic dysfunction – a report of two cases
by: Hubert Arasiewicz, et al.
Published: (2014-10-01)

Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study
by: Salvatore D’Angelo, et al.
Published: (2022-07-01)

Fixed-combination halobetasol propionate and tazarotene topical lotion decreases TNF-α and IL-17A levels in psoriatic lesions
by: Zoe Diana Draelos, et al.
Published: (2023-12-01)

Generalised pustular psoriasis – a case report and review of therapeutic approaches
by: Agnieszka Osmola-Mańkowska
Published: (2014-11-01)

Anti-TNFα Drugs and Interleukin Inhibitors: Epidemiological and Pharmacovigilance Investigation in COVID-19 Positive Patients
by: Zaira Maraia, et al.
Published: (2022-10-01)

Lower peripheral helper T cell levels in the synovium are associated with a better response to anti-TNF therapy in rheumatoid arthritis
by: Antonio Julià, et al.
Published: (2020-08-01)